Pertuzumab, is a targeted therapy used in the treatment of HER2-positive breast cancer. Here are the key points:
Purpose and Mechanism:
- Pertuzumab is a HER2 inhibitor that works by blocking HER2 receptors on cancer cells, preventing them from receiving growth signals.
- It is used for metastatic breast cancer and also in certain types of early-stage breast cancer before and after surgery.
Administration:
- Given as an intravenous infusion (IV) in a hospital or clinic.
- Typically administered once every 3 weeks.
- The first infusion takes about 60 minutes, and subsequent infusions may be shorter3.
Side Effects and Precautions:
- Common side effects include upper respiratory infections, anemia, vomiting, stomatitis, and pharyngitis.
- Serious side effects can include heart problems, so regular heart function checks are necessary during treatment.
- Temporary hair loss and skin rash may occur.
Remember to consult your healthcare provider for personalized advice. If you have further questions, feel free to ask! 😊
Pertuzumab
Strengths
30mg/ml 14ml
Container
Glass Vial
Use
It is used for metastatic breast cancer and also in certain types of early-stage breast cancer before and after surgery.
Targate
HER2